Page 161 - ASHG 2012 Annual Meeting Program Guide

150
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
990
W Application of molecular diagnostic techniques
on the study done on phosphatase and tensin
homologue deleted on chromosome 10 (PTEN).
R. Issa.
991
T Validation, fine-mapping, and characterization
of six genes related to testicular germ cell tumor in a
large Swedish-Norwegian case-parent, case-control
sample.
R. Karlsson, W. Kristiansen, K. E. Andreassen,
E. L. Aschim, R. M. Bremnes, O. Dahl, S. D. Fosså, O.
Klepp, C. W. Langberg, A. Solberg, S. Tretli, P. K. E.
Magnusson, H.-O. Adami, T. B. Haugen, T. Grotmol, F.
Wiklund.
992
F Genome-wide germline DNA autosomal copy
number variation analysis in Finnish
BRCA1/2
-
founder
mutation-negative hereditary breast and/or ovarian
cancer individuals.
K. M. Kuusisto, O. Akinrinade, M.
Vihinen, S.-L. Sallinen, J. Schleutker.
993
W
Mediator complex subunit 12
(
MED12
)
mutations
in uterine leiomyosarcomas.
M. M. McGuire, M. Jones,
G. Trucco, U. Surti, R. P. Edwards, A. Rajkovic.
994
T Association of breast cancer risk factors and
HLA-G
gene indel 14bp polimorphyms in a Brazilian population.
Y. C. N. Muniz, M. Damiani, L. D. Hausmann, B. S. Almeida,
B. Fernandes, R. T. Simıes, A. R. Marrero, I. R. Souza.
995
F Fine-mapping of prostate cancer susceptibility
locus 11q13.5.
R. Nurminen, R. Lehtonen, T. L. Tammela,
T. Wahlfors, J. Schleutker.
996
W Role of copy number variants in the nucleotide
excision repair pathway genes and breast cancer risk in
Puerto Rican women.
A. Pacheco Torres, J. Matta, J. Dutil.
997
T Screening of Finnish
RAD51C
founder mutations
in prostate and colorectal cancer patients.
L. M.
Pelttari, R. Nurminen, A. Gylfe, L. Aaltonen, J. Schleutker,
H. Nevanlinna.
998
F Exome sequencing in a familial testicular germ
cell tumor kindred.
K. A. Schrader, S. Shah, V. Joseph, R.
Murali, R. Rau-Murthy, K. Sarrel, I. Dolgalev, S. Cheguri,
C. Manschreck, N. Socci, A. Viale, A. Heguy, G. Bosl, D.
Feldman, M. Robson, Z. Stadler, K. Offit.
999
W
SLX4
mutation in hereditary breast cancer.
S. Shah, Y. Kim, I. Ostrovnaya, F. Lach, R. Murali, K.
Schrader, V. Joseph, K. Sarrel, R. Rau-Murthy, N. Hansen,
S. Cheguri, J. Littman, L. Zhang, K. Offit, A. Smogorzewska.
1000
T Contribution of
ARLTS1
to prostate cancer
susceptibility.
S. Siltanen, H. Rauhala, T. L. Tammela, P.
Kujala, T. Visakorpi, T. Wahlfors, J. Schleutker.
1001
F Meta-analysis of 25 prostate cancer associated
SNPs in high-risk prostate cancer families: New
evidence from the International Consortium for
Prostate Cancer Genetics.
C. Teerlink, S. Thibodeau, D.
Schaid, K. Cooney, E. Lange, C. Maier, J. Stanford, E. A.
Ostrander, J. Schleutker, G. Cancel-Tassin, O. Cussenot,
R. Eeles, D. Easton, W. Isaacs, J. Xu, J. Carpten, J. E.
Bailey-Wilson, F. Wiklund, A. Whittemore, W. Catalona,
W. Foulkes, N. Camp, L. Cannon-Albright, International
Hocking, S. G. Brown, E. A. Haan, S. Yu.
979
W Diagnostic array analysis and the necessity
of high quality SNP information.
R. Pfundt, J. Hehir-
Kwa, N. Leijsten, S. van Gessel, M. Wunderink,
T. Machielsen, R. van Beek, M. Banning, M. Rosario,
N. de Leeuw.
980
T Copy-number variation and UPD(16) mosaicism
in a patient with apple peel intestinal atresia, ocular
anomalies, microcephaly and bone-marrow failure.
F. A. T. de Vries, Y. van Bever, I. M. Appel, H. Kart, L. J. C.
M. van Zutven, H. B. Beverloo.
Cancer Genetics
981
W Tumor suppression in
Apc
Min/
1
mice by the
prostaglandin D
2
receptor PTGDR.
H. Lin, A. Kwong, O.
Lee, V. Buslon, S. French, E. Salido.
982
T Effects of Western-style diet and genetic
predisposition on the protein expression and cancer
susceptibility in normal colonic mucosa.
S. Lowndes,
D. Dermadi Bebek, M. Pussila, N. Reyhani, L. Sarantaus,
M. Nyström.
983
F The Jackson Laboratory Rare and Orphan
Disease Center.
S. Rockwood, C. Lutz, K. Fancher, A.
Picard, M. Sasner, L. Reinholdt, S. Murray, D. Bergstrom,
J. Morgan, L. Donahue, GRS Team.
984
W Genetic differences in transcript responses to
low-dose ionizing radiation identify tissue functions
associated with breast cancer susceptibility.
A. J.
Wyrobek, F. Marchetti, S. Bhatnagar, N. Duru, J. Han, Z.
Hu, J.-H. Mao, J. W. Gray, A. M. Snijders.
985
T Association of the
HLA-G
gene polymorphisms
with cervical cancer risk.
T. Chang, Y. Yang, Y. Lee, T.
Chen, S. Chang, W. Lin.
986
F Association of the
HOXB13
G84E variant with
familial, sporadic, and aggressive prostate cancer: The
Mayo Clinic experience.
M. S. DeRycke, L. S. Tillmans,
S. K. McDonnell, S. M. Riska, J. Xu, Y. W. Asmann, D. J.
Schaid, S. N. Thibodeau, International Consortium for
Prostate Cancer Genetics.
987
W The miR-29 family of microRNA genes and let-7i
associate with gastric cancer in European populations:
Results from the EPIC-EURGAST study.
Y. Espinosa-
Parrilla, X. Muñoz, C. Bonet, N. García, A. Venceslá, E.
Riboli, C. A. González, N. Sala on behalf of EPIC Gastric
Cancer Working Group.
988
T 3’UTR variation in
PTEN
and
PTENP1
:
Implications for microRNA binding.
B. G. Hernandez, C.
LaViolette, T. Begay, J. A. Wilder.
989
F Replacement therapy for lung adenocarcinoma
risk in never-smoking women.
C. Hsiao, K. Chen, G.
Chang, Y. Tsai, W. Su, Y. Chen, M. Huang, C. Hsiung, C.
Chen, P. Yang, GELAC Study Group.